Phase II Randomized Trial of the Combination of Cetuximab and Sorafenib or Single Agent Cetuximab
Phase 2 Completed
55 enrolled 10 charts
Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin
Phase 2/3 Completed
196 enrolled 31 charts
Biomarkers for Oral Cancer
Completed
80 enrolled
Anti-PD-L1/TGF-beta Trap (M7824) Alone and in Combination With TriAd Vaccine and N-803 for Resectable Head and Neck Squamous Cell Carcinoma Not Associated With Human Papillomavirus Infection
Phase 1/2 Completed
21 enrolled 16 charts
Sunitinib Malate in Treating Patients With Thyroid Cancer That Did Not Respond to Iodine I 131 and Cannot Be Removed by Surgery
Phase 2 Completed
63 enrolled 12 charts
Onalespib in Treating Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck Receiving Radiation Therapy and Cisplatin
Phase 1 Completed
2 enrolled
Hearing Loss and the Effects of Statin Drugs in People With Head and Neck Squamous Cell Carcinoma Treated With Cisplatin Chemoradiation
Completed
32 enrolled
Sorafenib Tosylate in Treating Patients With Metastatic, Locally Advanced, or Recurrent Medullary Thyroid Cancer
Phase 2 Completed
21 enrolled 15 charts
A Follow-up Study of Women Evaluated and Treated for Infertility
Completed
12,193 enrolled
Cabozantinib S-Malate in Treating Younger Patients With Recurrent or Refractory Solid Tumors
Phase 1 Completed
41 enrolled 20 charts
Ipilimumab, Cetuximab, and Intensity-Modulated Radiation Therapy in Treating Patients With Previously Untreated Stage III-IVB Head and Neck Cancer
Phase 1 Completed
19 enrolled
M7824 in Subjects With HPV Associated Malignancies
Phase 2 Completed
57 enrolled 20 charts
Studies of Inherited Diseases of Metabolism
Completed
969 enrolled
Cisplatin, Intensity-Modulated Radiation Therapy, and Pembrolizumab in Treating Patients With Stage III-IV Head and Neck Squamous Cell Carcinoma
Phase 1 Completed
37 enrolled
Studies of Elevated Parathyroid Activity
Phase 2 Completed
1,553 enrolled 8 charts
Pioglitazone Hydrochloride in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia
Phase 2 Completed
21 enrolled 6 charts
Cediranib Maleate With or Without Lenalidomide for the Treatment of Thyroid Cancer
Phase 1/2 Completed
127 enrolled 18 charts
Depsipeptide in Unresectable Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Phase 2 Completed
14 enrolled 6 charts
Study to Evaluate the Natural History of Head and Neck Cancer Precursors in Taiwan
Completed
3,576 enrolled
Family Study of Head and Neck Cancers in Taiwan
Completed
3,795 enrolled
Hyperthyroid Follow-Up Study
Completed
35,593 enrolled
Scientific Protocol for the Study of Thyroid Cancer and Other Thyroid Disease in Ukraine Following the Chernobyl Accident
Completed
23,143 enrolled
Metabolic Effects of Synthetic Thyroid Hormone for Thyroid Cancer Treatment
Completed
16 enrolled
Vorinostat in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma
Phase 2 Completed
30 enrolled 16 charts
Cigarette Smoking and Oral Microbiota
Completed
50 enrolled
Molecular Genetics Study of Nasopharyngeal Carcinoma: Characterization of NCP Susceptibility Gene(s)
Completed
6,490 enrolled
Cancer and Other Disease Risks in U.S. Nuclear Medicine Technologists
Completed
229 enrolled
The Incidence of Breast and Other Cancers Among Female Flight Attendants
Completed
6,093 enrolled
Scientific Protocol for the Study of Thyroid Cancer and Other Thyroid Disease in Belarus Following the Chernobyl Accident
Completed
19,456 enrolled
Pazopanib Hydrochloride in Treating Patients With Advanced Thyroid Cancer
Phase 2 Completed
152 enrolled 16 charts
Natural History of Salivary Gland Dysfunction and Sjogren's Syndrome
Completed
560 enrolled
Radiation Therapy and Bortezomib and Cetuximab With or Without Cisplatin to Treat Head and Neck Cancer
Phase 1 Completed
3 enrolled
Studies of Thyroid Abnormalities in Northeastern Kazakhstan Associated With Nuclear Weapons Testing
Completed
2,997 enrolled
Radiation Exposure and Thyroid Disease in Kazakhstan
Completed
117 enrolled
PS-341 and Radiation to Treat Advanced Cancer of the Head and Neck
Phase 1 Completed
25 enrolled
Akt Inhibitor MK2206 in Treating Patients With Progressive, Recurrent, or Metastatic Adenoid Cyst Carcinoma
Phase 2 Completed
16 enrolled 7 charts
Bortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy
Phase 2 Completed
24 enrolled 6 charts
Cetuximab With or Without Tivantinib in Treating Patients With Head and Neck Cancer That Is Recurrent, Metastatic, or Cannot Be Removed by Surgery
Phase 2 Completed
81 enrolled 14 charts
Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Phase 1/2 Completed
58 enrolled
Effect of AdhAQP1 on Salivary Flow in Patients Treated With Radiation for Head and Neck Cancer
Phase 1 Completed
17 enrolled
Study of Thyrotropin-Releasing Hormone in Normal Volunteers and in Patients With Thyroid or Pituitary Abnormalities
Phase 2 Completed
96 enrolled 6 charts
Informed Consent for Whole Genome Sequencing: Ideals and Norms Referenced by Early Participants
Completed
30 enrolled
A Phase II Trial of Valproic Acid in Patients With Advanced Thyroid Cancers of Follicular Cell Origin
Phase 2 Completed
13 enrolled 11 charts
Dasatinib in Treating Patients With Recurrent or Metastatic Malignant Salivary Gland Tumors
Phase 2 Completed
55 enrolled 8 charts
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated Cancers
Phase 2 Completed
29 enrolled 12 charts
Bevacizumab, Cisplatin, Radiation Therapy, and Fluorouracil in Treating Patients With Stage IIB, Stage III, Stage IVA, or Stage IVB Nasopharyngeal Cancer
Phase 2 Completed
46 enrolled 10 charts
Rapamycin Therapy in Head and Neck Squamous Cell Carcinoma
Phase 1/2 Completed
37 enrolled 6 charts
Akt Inhibitor MK2206 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Phase 2 Completed
21 enrolled 11 charts
A Phase II Trial of Cetuximab and Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer
Phase 2 Completed
48 enrolled 14 charts
Recombinant Interleukin-15 in Treating Patients With Advanced Melanoma, Kidney Cancer, Non-small Cell Lung Cancer, or Squamous Cell Head and Neck Cancer
Phase 1 Completed
20 enrolled